City

Clinical trials near Amsterdam, Netherlands

Active studies with a listed research site in Amsterdam, Netherlands.

13active studies

10recruiting now

21countries represented

62largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Overweight, ObesityCondition

Semaglutide, PlaceboTreatment

Belgium, Bulgaria62 locations

Novo Nordisk A/SSponsor

Updated 2026-08-18 · NCT07770841See eligibility →

Recruiting nowNot applicable

DIStal gastriC Bypass OUtcome in Revision SurgEry After Roux-en-y Gastric Bypass

Obesity, Morbid, Weight GainCondition

Distal gastric bypassTreatment

Netherlands8 locations

St. Antonius HospitalSponsor

Updated 2026-04-27 · NCT04894838See eligibility →

Recruiting nowNot applicable

Plant-based Protein-rich Weight Loss Intervention in 55+ Adults With Obesity

ObesityCondition

More plant-based protein intake during weight lossTreatment

Netherlands1 locations

Amsterdam University of Applied SciencesSponsor

Updated 2026-02-24 · NCT07429136See eligibility →

Recruiting nowNot applicable

Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery

MASLDCondition

[6,6-D2]-labeled glucose (intravenous), Saline (0.9% sodium chloride infusion)Treatment

Netherlands1 locations

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Sponsor

Updated 2026-01-08 · NCT07326865See eligibility →

Recruiting nowNot applicable

A Combined Lifestyle Intervention Delivered by Physio/exercise Therapists for Patients with Persistent Low Back Pain and Overweight or Obesity

Low Back PainCondition

Combined lifestyle intervention and LBP care (physiotherapy, exercise therapy)Treatment

Netherlands1 locations

Willeke BoonstraSponsor

Updated 2025-01-24 · NCT06594796See eligibility →

Recruiting nowNot applicable

Screening for Malnutrition in Obese Patients

Overweight and Obese Adults, Malnutrition or Risk of MalnutritionCondition

Intervention not listedTreatment

Netherlands3 locations

HAN University of Applied SciencesSponsor

Updated 2024-11-08 · NCT06626360See eligibility →

Recruiting nowNot applicable

Global Research Initiative for Patients Screening on MASH

MASH, MASLDCondition

Intervention not listedTreatment

Belgium, Czechia13 locations

Julius ClinicalSponsor

Updated 2024-08-01 · NCT05651724See eligibility →

Recruiting nowNot applicable

Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial

Bariatric Surgery Candidate, ObesityCondition

OAGB, RYGBTreatment

Netherlands2 locations

FlevoziekenhuisSponsor

Updated 2024-04-23 · NCT04852198See eligibility →

Recruiting nowNot applicable

Effect of Timed-Restricted Eating on Metabolic Health

Obesity, Non-Alcoholic Fatty Liver DiseaseCondition

Early time restricted eating, Late time restricted eatingTreatment

Netherlands1 locations

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Sponsor

Updated 2023-09-29 · NCT06061042See eligibility →

Recruiting nowNot applicable

The European NAFLD Registry

NAFLD, NASHCondition

Intervention not listedTreatment

Belgium, Finland37 locations

Newcastle UniversitySponsor

Updated 2023-01-06 · NCT04442334See eligibility →

Opening soonNot applicable

Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity

Overweight , Obesity, Obesity (Disorder)Condition

TirzepatideTreatment

Netherlands10 locations

Radboud University Medical CenterSponsor

Updated 2026-03-31 · NCT07504172See eligibility →

Active, not recruitingPhase 1

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

ObesityCondition

BI 456906, SemaglutideTreatment

Netherlands1 locations

Boehringer IngelheimSponsor

Updated 2026-09-02 · NCT05202353See eligibility →

Active, not recruitingPhase 2

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Overweight, ObesityCondition

Tirzepatide, PlaceboTreatment

Austria, Canada27 locations

Eli Lilly and CompanySponsor

Updated 2026-05-08 · NCT05536804See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Amsterdam, Netherlands

Current studies

Related cities